NCT00095212View on ClinicalTrials.gov

Androgen Effects in HIV-infected Women

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

February 28, 2009

Conditions
HIV Infection
Interventions
DRUG

1 Transdermal Testosterone (Patch)

300 micrograms twice a week

DRUG

2 Placebo Patch

Placebo patch (0 micrograms of testosterone) applied twice a week

Trial Locations (1)

02114

Mass General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00095212 - Androgen Effects in HIV-infected Women | Biotech Hunter | Biotech Hunter